Cargando…
Eculizumab and Complement Activation in Anti−glomerular Basement Membrane Disease
Autores principales: | Nithagon, Pravarut, Cortazar, Frank, Shah, Sujal I., Weins, Astrid, Laliberte, Karen, Jeyabalan, Anushya, Niles, John, Zonozi, Reza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8484114/ https://www.ncbi.nlm.nih.gov/pubmed/34622110 http://dx.doi.org/10.1016/j.ekir.2021.07.001 |
Ejemplares similares
-
Treatment of Aggressive Antineutrophil Cytoplasmic Antibody–Associated Vasculitis With Eculizumab
por: Huizenga, Noah, et al.
Publicado: (2019) -
Treatment of Gemcitabine-Induced Thrombotic Microangiopathy Followed by Gemcitabine Rechallenge With Eculizumab
por: Efe, Orhan, et al.
Publicado: (2021) -
Rituximab for Anti–Glomerular Basement Membrane Disease
por: Jain, Rashmi, et al.
Publicado: (2018) -
Binding Truths: Seronegative Anti-Glomerular Basement Membrane Disease Mediated by IgM Anti-Glomerular Basement Membrane Antibodies
por: Antonelou, Marilina, et al.
Publicado: (2023) -
A Case of Glomerulopathy Associated With Monoclonal Glomerular Basement Membrane Antibody
por: Bonilla, Marco, et al.
Publicado: (2021)